Other ingredients: hypoallergenic plant fiber (cellulose), vegetarian capsule (cellulose, water)
Possible Side Effects Mild digestive discomfort with oral supplements Skin rashes in rare cases Kidney strain with very high doses taken long-term Risk of infection or adverse reaction if IV is administered without proper sterile protocol Who Should Avoid It Pregnant or breastfeeding women People with asthma (high doses may trigger bronchospasm) Anyone with a known sensitivity to sulphur compounds Those with pre-existing kidney or liver conditions The risks are largely manageable under proper supervision
You can also consume l carnitine and creatine together if you want to gain strength along with fat burning
Please ensure your facility is equipped with proper handling protocols before ordering.
Dec 18, 2025, 08:00 ET CagriSema 2.4 mg/2.4 mg is an investigational fixed-dose injectable medicine that combines the novel amylin analogue, cagrilintide, with semaglutide to target complementary obesity-related pathways 1,2 In the REDEFINE 1 phase 3 trial, adults with obesity, or overweight with at least one obesity-related complication, taking CagriSema lost an average of 23% body weight when evaluating the treatment effect if all patients stayed on treatment *2 Novo Nordisk continues to build on its 100-year-plus legacy of science and innovation, with potential new treatments in obesity PLAINSBORO, N.J
Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome
